Clinical Trials Logo

Safety Issues clinical trials

View clinical trials related to Safety Issues.

Filter by:

NCT ID: NCT04403334 Completed - Safety Issues Clinical Trials

Postoperative Safety Outcomes of Intraoperative Intracameral Preservative-Free Moxifloxacin Versus Levofloxacin

Start date: January 2, 2018
Phase: Phase 4
Study type: Interventional

Comparative safety study of intracameral levofloxacin versus moxifloxacin for postoperative infection prophylaxis

NCT ID: NCT04365608 Completed - Influenza Clinical Trials

Prehospital Intubation of COVID-19 Patient With Personal Protective Equipment

Start date: March 20, 2020
Phase: N/A
Study type: Interventional

The safety and efficacy of a laryngoscopy as a primary intubation tool in urgent endotracheal intubation of cardiac arrest patients with suspected/confirmed COVID-19 has not been well-described in the literature. This study will answer whether using a Vie Scope laryngoscope will impact on the efficacy and safety of intubation compared with a traditional direct laryngoscopy.

NCT ID: NCT04360655 Not yet recruiting - Safety Issues Clinical Trials

Bronchoscopic Microwave Intervention Treatment in Advanced Central NSCLC

Start date: May 1, 2020
Phase: N/A
Study type: Interventional

A randomized, prospective study of the efficacy and safety of the first-line treatment in advanced central non-small cell lung cancer patients by anti-PD-1 / PD-L1 monoclonal antibody and chemotherapy versus anti-PD-1 / PD-L1 monoclonal antibody and chemotherapy combined with bronchoscopic microwave intervention

NCT ID: NCT04335045 Completed - Safety Issues Clinical Trials

Phase I Study of PH100 (Ecklonia Cava Phlorotannins)

Start date: September 25, 2013
Phase: Phase 1
Study type: Interventional

The purpose of this study was to determine the safety and tolerability of PH100, a purified phlorotannins from a brown alga Ecklonia cava and the pharmacokinetics of its major compounds 8,8'-bieckol, dieckol, and phlorofucofuroeckol A (PFF-A), after single, ascending, oral doses of PH100 Capsules (over-encapsulated tablets) in healthy adult volunteers.

NCT ID: NCT04326114 Not yet recruiting - Safety Issues Clinical Trials

Effectiveness and Safety of Respiratory Training in the Prevention and Severity of COVID-19

Start date: July 26, 2020
Phase: N/A
Study type: Interventional

A randomized controlled clinical trial will be carried out using inspiratory and expiratory training devices on healthy subjects recruited in social networks and university environments. The aim will be to determine the effectiveness and safety in the prevention and severity of COVID-19 disease by a respiratory training with inspiratory and expiratory devices.

NCT ID: NCT04311476 Completed - Safety Issues Clinical Trials

Autologous Cord Blood Cells for Prevention of BPD in Preterm

Start date: July 1, 2018
Phase: Phase 2
Study type: Interventional

To study the effect of Autologous cord blood cells infusion on prevention of bronchopulmonary dysplasia in very preterm neonates

NCT ID: NCT04301895 Completed - Acute Pain Clinical Trials

Pupillary Unrest in Ambient Light, and Relationship to Opioid-Induced Respiratory Depression

Start date: April 30, 2019
Phase: Phase 1
Study type: Interventional

Volunteers will receive a weight-based opioid (remifentanil) infusion for 10 minutes. In the first run, serial pupillary measurements (pupillary unrest, pupil diameter) will be taken at baseline, and at 2.5-minute intervals during the infusion and a 25-minute recovery period afterwards. After a washout period, the experiment will be repeated in each subject (second run). The two runs differ only by presence versus absence of verbal interaction.

NCT ID: NCT04270786 Recruiting - Safety Issues Clinical Trials

Early De-escalation of Empirical Antibiotics Treatment for Neutropenic Fever

Start date: January 1, 2020
Phase: N/A
Study type: Interventional

This is a randomized study to evaluate the safety and feasibility of early de-escalation of empirical antibiotics treatment in neutropenic fever patients undergoing hematopoietic stem cell transplantation (HSCT). In case of afebrile for 72 hours with empirical antibiotics treatment, patients will be randomized into 2 groups. In the early de-escalation group, antibiotics treatment will be stopped and prophylaxis with levofloxacin will be resumed. In the control group, the empirical treatment will continue until recovery of neutropenia or at least for 7 days.

NCT ID: NCT04268758 Withdrawn - Safety Issues Clinical Trials

A Single-center Study Designed to Evaluate the Safety and Efficacy of Tulipon

Start date: June 1, 2021
Phase:
Study type: Observational

Subjects who normally use tampons will use Tulipon device during one menstrual cycle. Baseline and post usage clinical evaluation will be performed for safety testing.

NCT ID: NCT04226482 Completed - Safety Issues Clinical Trials

Review of Efficacy of Used ultraSonic Energy Device

REUSED
Start date: May 27, 2019
Phase: N/A
Study type: Interventional

Single-use medical instruments are intended by the manufacturers for single-use only or for single-patient-use only. Nevertheless, single-use instruments are being reused more than once in many countries around the world. The reasons are mainly economic in developing countries and environmental in developed countries. Concerns are being raised regarding reused instruments sterility and efficacy. Since there is paucity of evidence on safety of multiple use of single-use instruments in surgery, we decided to conduct a clinical study comparing the same surgical procedure performed with new versus reused surgical instrument. We decided to study laparoscopic appendectomy which is a simple and the most common emergency surgery. Instrument under the scrutiny is ultrasonic scalpel which uses high-frequency ultrasound vibration for coagulating and cutting tissue. In the studied period of time, all eligible patients with acute appendicitis will be randomized in two groups, first having surgery with new device and the second having surgery with reused device. Removed appendix will be analyzed for lateral thermal damage and the patients will be followed-up for one month for potential differences in clinical outcomes like pain-killers consumption, length of stay and postoperative complications.